BioInvent International AB brings forward publication of Year-end report 2020
Lund, Sweden – February 23, 2021 – BioInvent International AB (“BioInvent”) (Nasdaq Stockholm: BINV) today announces that the company changes the date for publication of the year-end report 2020, and the interim report for the fourth quarter 2020, to Tuesday February 23, 2021. Earlier communicated publication date was February 25, 2021. About BioInventBioInvent International AB (OMXS: BINV) is a clinical stage company that discovers and develops novel and first-in-class immuno-modulatory antibodies for cancer therapies, with four programs in clinical development. The Company’s